Natco Pharma Share Price
Small Cap | Pharmaceuticals and health care | NSE: NATCOPHARM | BSE: 524816
₹797.75 
4.75 (0.60 %)
Last Updated: 21 Feb 2025 04:01 PM
BEARISH
Overview
Open (₹) 795.90
High (₹) 815.45
Low (₹) 777.30
Prev. Close (₹) 793.00
Volume 59,345
VWAP (₹) 791.81
ROCE (%) 28.52
Industry P/E 43.99
TTM P/E 7.66
P/B Ratio 2.44
Market Cap (₹) Cr.14,292.07
Dividend Yield (%)1.19
EPS (₹) 77.34
ROE23.65%
Sales Growth (%) 47.72
Profit Growth (%)94.09
Day Range
815.45815.45
52 Week Range
777.301,638.35
Historical Returns
Returns (6M)
-48.98 %
Returns (1Y)
-22.31 %
Returns (3Y)
-3.26 %
Returns (5Y)
24.52 %
Returns (6M)
-48.98 %
Returns (1Y)
-22.31 %
Returns (3Y)
-3.26 %
Returns (5Y)
24.52 %
SWOT Analysis
- Effectively using its capital to generate profits - ROCE improved in the last year
- Company with (97.40%) TTM EPS Growth
- Company with Low Debt
- Book value per share improving over the last 2 years
- Efficient in managing Assets to generate Profits - ROA improved since last year
- Strong cash generating ability from core business - Improving Cash Flow from operation for last 2 years
- Company with 97.40% positive TTM EPS growth
- Increasing Annual Revenue for Past 2 Years
- Price above the pivot point indicates bullish sentiment.
Technicals
Technical Rating
BEARISHRSI 44.31
MFI 11.22
ATR 67.72
Commodity Channel Index -123.08
ROC125 -48.87
ROC21 -36.53
Williams %R -96.37
Resistance & Support
| Type | Resistance 1 | Resistance 2 | Resistance 3 | PP | Support 1 | Support 2 | Support 3 |
|---|---|---|---|---|---|---|---|
| Current | 816.36 | 834.98 | 854.51 | 796.83 | 778.21 | 758.68 | 740.06 |
| Week Ago | 942.35 | 1,001.00 | 1,038.05 | 905.30 | 846.65 | 809.60 | 750.95 |
| Month Ago | 1,260.40 | 1,277.45 | 1,287.65 | 1,250.20 | 1,233.15 | 1,222.95 | 1,205.90 |
EMA & SMA
797.75
Current Price
Bullish Moving Averages
0
Bearish Moving Averages
20
5 Day 837.79
9 Day 996.93
10 Day 1026.63
12 Day 1082.10
14 Day 1085.07
20 Day 1098.74
26 Day 1139.16
50 Day 1250.21
100 Day 1319.88
200 Day 1296.85
Deals & Announcements
Bulk and Block Deals
| Client Name | Deal Type | Action | Date | Avg. Price | Quantity | Exchange |
|---|---|---|---|---|---|---|
| JUPITER SOUTH ASIA INVESTMENT COMPANY LIMITED | block | Sell | 21 Feb, 2024 | ₹1,039.15 | 1,98,742 | BSE |
| THE JUPITER GLOBAL FUND-JUPITER INDIA SELECT | block | Buy | 21 Feb, 2024 | ₹1,039.15 | 1,98,742 | BSE |
| BNP PARIBAS ARBITRAGE | block | Sell | 25 Jan, 2024 | ₹859.20 | 6,62,733 | BSE |
| SOCIETE GENERALE | block | Buy | 25 Jan, 2024 | ₹859.20 | 6,62,733 | BSE |
| MARSHALLWACEINVESTMENTSTRATEGIESMARKETNEUTRALTOPSFUND | block | Buy | 25 Jan, 2024 | ₹859.20 | 1,49,926 | BSE |
| ISHARES INDIA SC MAURITIUS COMPANY | block | Sell | 25 Oct, 2022 | ₹593.90 | 22,874 | BSE |
| ISHARES CORE EMERGING MARKETS MAURITIUS CO | block | Sell | 25 Oct, 2022 | ₹593.90 | 1,93,938 | BSE |
| ISHARES MSCI INDIA SMALL-CAP ETF | block | Buy | 25 Oct, 2022 | ₹593.90 | 22,874 | BSE |
| ISHARES CORE MSCI EMERGING MARKETS ETF | block | Buy | 25 Oct, 2022 | ₹593.90 | 1,93,938 | BSE |
| ISHARES INDIA SC MAURITIUS COMPANY | block | Sell | 17 Oct, 2022 | ₹598.00 | 22,852 | BSE |
Insider Trading
| Date | Name | Action | Avg. Price | Quantity | Deal Value |
|---|---|---|---|---|---|
| 31 Dec, 2024 | Lakshminarayana Bolisetty | Disposal | ₹1,391.61 | 2,000 | BSE |
| 31 Dec, 2024 | Venkatrao Tummala | Disposal | ₹1,380.3768 | 2,500 | BSE |
| 21 Dec, 2024 | SADA SIVA RAO NANNAPANENI | Disposal | ₹1,467.2168 | 5,000 | BSE |
| 02 Dec, 2024 | RAHUL TUMMALA | Disposal | ₹1,352.855 | 1,000 | BSE |
| 28 Nov, 2024 | RAHUL TUMMALA | Disposal | ₹1,359.243333333333333333333333 | 900 | BSE |
| 12 Sept, 2024 | AMIT SOGANI | Disposal | ₹1,617.57 | 1,500 | BSE |
| 06 Sept, 2024 | SUNIL KOTARU | Disposal | ₹1,556.625190839694656488549618 | 1,310 | BSE |
| 05 Sept, 2024 | G VENKATA RAMANA | Disposal | ₹1,533.021 | 2,000 | BSE |
| 02 Sept, 2024 | SUBBA RAO MENTE | Disposal | ₹1,513.9988 | 20,000 | BSE |
| 26 Aug, 2024 | DHRUVA KUMAR NANNAPANENI | Disposal | ₹1,560.088333333333333333333333 | 600 | BSE |
Corporate Actions
| Announcement Date | Subject | Ex - Date | Record Date |
|---|---|---|---|
| 12 Feb, 2025 | Rs.1.5000 per share(75%)Third Interim Dividend | 18 Feb, 2025 | 18 Feb, 2025 |
| 12 Nov, 2024 | Rs.1.5000 per share(75%)Second Interim Dividend (RD & XD dates revised) | 27 Nov, 2024 | 27 Nov, 2024 |
| 12 Aug, 2024 | Rs.3.0000 per share(150%)Interim Dividend | 23 Aug, 2024 | 23 Aug, 2024 |
Announcements
| Date | Source | Detail |
|---|---|---|
| 19 Feb, 2025 | BSE India | Q3 FY25 Earning Call Transcript |
| 19 Feb, 2025 | NSE India | Natco Pharma Limited has informed the Exchange about Transcript |
| 13 Feb, 2025 | NSE India | Natco Pharma Limited has informed the Exchange about Link of Recording |
| 13 Feb, 2025 | BSE India | Audio recording of earnings conference call Q3 FY25 |
| 13 Feb, 2025 | NSE India | Natco Pharma Limited has informed the Exchange about Copy of Newspaper Publication |
| 12 Feb, 2025 | NSE India | Natco Pharma Limited has informed the Exchange about Investor Presentation |
| 12 Feb, 2025 | BSE India | Q3 FY25 Earnings Presentation |
| 12 Feb, 2025 | NSE India | NATCO PHARMA LIMITED has informed the Exchange regarding Outcome of Board Meeting held on 12-Feb-2025 for Dividend |
| 12 Feb, 2025 | NSE India | NATCO PHARMA LIMITED has informed the Exchange about Change in Directors/ Key Managerial Personnel/ Auditor/ Compliance Officer/ Share Transfer Agent |
| 12 Feb, 2025 | BSE India | Integrated Filing - Financials |
Board Meetings
| Purpose | Details | Meeting Date | Broadcast Date |
|---|---|---|---|
| Quarterly Results & Interim Dividend | -- | 31 Jan, 2025 | 12 Feb, 2025 |
| Quarterly Results & Interim Dividend | -- | 29 Oct, 2024 | 12 Nov, 2024 |
| Quarterly Results & Interim Dividend | -- | 29 Jul, 2024 | 12 Aug, 2024 |
| Audited Results | -- | 10 May, 2024 | 27 May, 2024 |
| Quarterly Results & Interim Dividend | -- | 05 Feb, 2024 | 14 Feb, 2024 |
| Quarterly Results & Interim Dividend | -- | 06 Nov, 2023 | 14 Nov, 2023 |
| Quarterly Results & Interim Dividend | -- | 02 Aug, 2023 | 09 Aug, 2023 |
| Audited Results | -- | 22 May, 2023 | 29 May, 2023 |
| Buy Back of shares | -- | 10 Mar, 2023 | 08 Mar, 2023 |
| Quarterly Results & Interim Dividend | -- | 01 Feb, 2023 | 09 Feb, 2023 |
Share Holding Pattern
| Owner Name | Dec, 2024 | Sept, 2024 | Jun, 2024 | Mar, 2024 | Dec, 2023 |
|---|
About Natco Pharma
Natco Pharma is a Public Limited Listed company incorporated on 19/09/1981 and has its registered office in the State of Telangana, India. Company’s Corporate Identification Number(CIN) is L24230TG1981PLC003201 and registration number is 003201. Currently Company is involved in the business activities of Manufacture of pharmaceuticals, medicinal chemical and botanical products. Company’s Total Operating Revenue is Rs. 3568.90 Cr. and Equity Capital is Rs. 35.80 Cr. for the Year ended 31/03/2024. Read More
Parent Organisation
Not Applicable
Founded
1981
Managing Director
-- --
NSE Symbol
NATCOPHARM
Natco Pharma Management
| Name | Designation |
|---|---|
| Mr. V C Nannapaneni | Chairman & Ind.Director |
| Mr. Rajeev Nannapaneni | Director & CEO |
| Mr. P S R K Prasad | Director & Exe. VP (Corp. Engg. Services) |
| Dr. D Linga Rao | Director & President (Tech. Affairs) |
| Dr. Pavan Ganapati Bhat | Director |
| Mr. D Vijaya Bhaskar | Independent Director |
| Mr. A D M Chavali | Independent Director |
| Dr. Kantipudi Suma | Addnl. & Ind.Director |
| Mr. Nitin Jain | Addnl. & Ind.Director |
| Mr. Lakshminarayana Bolisetty | Addnl. & Ind.Director |
Peer Comparison
| Stocks | Market Cap | Market Price | 52 Week Low-High |
|---|---|---|---|
| SunPhrmInds | ₹4,46,576.22 | ₹1,643.75  ₹1,669.30(-1.53%) | ₹1,249.800 - ₹1,960.200 |
| Divis Labora | ₹1,56,123.40 | ₹5,757.05 ₹5,978.30(-3.70%) | ₹3,350.050 - ₹6,448.750 |
| Cipla | ₹1,21,675.13 | ₹1,475.75 ₹1,479.70(-0.27%) | ₹1,240.700 - ₹1,702.000 |
| ManKind Phar | ₹1,18,478.90 | ₹2,327.75 ₹2,348.45(-0.88%) | ₹1,910.100 - ₹3,050.000 |
| DrReddysLab | ₹1,15,939.04 | ₹1,151.80 ₹1,170.95(-1.64%) | ₹1,104.690 - ₹1,420.200 |
FAQs on Natco Pharma
What is the share price of Natco Pharma?
The share price of Natco Pharma on 21 Feb, 2025 is ₹ 797.75.
What is 52W high and 52W low share price of Natco Pharma?
The highest and lowest 52W share prices of Natco Pharma are ₹ 1638.350 and ₹ 792.400
What is the market cap of Natco Pharma?
The market capitalization of Natco Pharma as of 21 Feb, 2025 is ₹ 14,292.07 Crores
What is the P/E ratio of Natco Pharma?
The current P/E ratio of Natco Pharma as of 21 Feb, 2025 is 43.99
What is the PB ratio of Natco Pharma?
The PB ratio of Natco Pharma as of 21 Feb, 2025 is 2.44
Top Gainers
948IHFL26I
IBHFL NCD186
₹845.00
₹705.00 (0.20%)
GREAVESCOT
Greaves
₹281.85
₹234.90 (0.20%)
ASHSI
Ashirwd Stl
₹45.66
₹38.05 (0.20%)
CAPRO
Caprola.Chem
₹62.40
₹52.00 (0.20%)
Top Losers
DHANBANK
Dhanalak.Bnk
₹32.19
₹35.97 (-0.11%)
08MPD
08MPD
₹8.66
₹9.62 (-0.10%)
BALTE
BalurghtTran
₹27.13
₹31.24 (-0.13%)
DARSHANORNA
Darshan Orna
₹4.57
₹5.07 (-0.10%)
Market Indices
Sensex
₹78,699.07
₹78,472.48 (0.00%)